PATENT CLAIM ANALYSIS

Application Number: 15880697
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-09
Patent Classification: ["514", "009000"]

Abstract:
The present disclosure is directed to gender, age, and dose effects of desmopressin on reducing nocturnal voids, increasing an initial period of undisturbed sleep, and/or reducing nocturnal urine volume.

Claim (Index 148):
The method according to  claim 141 , wherein the patient is over 65 years of age with a serum sodium level of at least 135 mmol/L after administration.

Metadata:
- Claim Count in Document: 95.0
- Percentile: 86.0
- Lexical Diversity: 1.21429
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12469801', '14143866', '12173074', '13378778', '11744615']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8183669287382581
- 35 USC 102 Novelty (BERT): 0.7093644748626826
- Combined Prediction Score: 0.8074666833507006
- Mean Citation Score: 403.029664
- Max Citation Score: 646.3669
- Similarity Product: 607.2482786951899

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test